Purified particles of rhinovirus type 14 lose infectivity during incubation at 34.5 C as a result of fragmentation of RNA genomes within intact virions.
Purified particles of rhinovirus type 14 lose infectivity during incubation at 34.5 C as a result of fragmentation of RNA genomes within intact virions.
The infectious genome of several different rhinoviruses has been characterized as a singlestranded RNA molecule with a molecular weight of 2.2 x 106 to 2.8 x 106 (1, 3, 6, 7, 9, 11) . Extraction of RNA from purified preparations of different rhinovirions has yielded, in addition to genomic RNA, appreciable quantities of RNA molecules which are much smaller in size than genomic RNA (3, 8, 9) . Data is presented which shows that incubation of purified particles of rhinovirus type 14 (RV14) at 34.5 C, a temperature optimum for growth of this virus (4) , promotes formation of subgenomic RNA fragments. The results of several experiments suggest that fragmentation of genomic RNA occurs in situ within virus particles during incubation.
[8H ]uridine-labeled RV14 was prepared in HeLA cell cultures and purified by banding in CsCl gradients, as previously described (3), or by centrifugation (47,500 rpm for 36 min in the Spinco SW50L rotor at 4 C) into 5 to 30% sucrose gradients in TST buffer (0.2% tryptosephosphate broth, 0.1 M NaCl, and 0.05 M Tris, pH 7.4). Fractions containing coipcident maxima in radioactivity and plaque-forming units (PFU) were dialyzed versus TST buffer containing penicillin (100 U/ml) and streptomycin (100 ug/ml) for 16 h at 4 C. Methods for cultivation of HeLa and KB cells and plaque assay of RV14 have been reported (10) . Viral RNA or ribosomal RNA were extracted from particles and KB cells, respectively, with phenol and sodium dodecyl sulfate (3). The methods for plaque assay and radioactivity measurements of viral RNA were previously outlined (3) .
Loss of infectivity in virus particles after incubation at 34. 5 (2), suggesting that inactivation involved a mechanism directed primarily against viral RNA.
The loss in infectivity in RV14 particles could be attributed to fragmentation of viral RNA to noninfectious subgenomic fragments (Fig. 1) . Virus was purified by the CsCl method and incubated for 24 h at 34.5 or held at -90 C. In this experiment, incubation reduced the original virus titer (3.8 x 109 PFU/ml) by 64%. RNA was extracted and centrifuged into linear 5 to 20% sucrose gradients. Each fraction was assayed for infectivity and radioactivity. Most infectivity was associated with the major 31S genomic RNA (3) peak of radioactivity in either sample. Subgenomic RNA fragments of approximately 3.5 x 10' daltons in size were never found in any significant quantities in these experiments, even when purified particles were incubated for 120 h at 34.5 C. Analysis of the size of subgenomic RNA by polyacrylamide gel electrophoresis (3) showed that subgenomic RNA was heterogeneous in size, varying from 1.5 x 106 to approximately 360,000 daltons. As recovery of trichloroacetic acid-insoluble 'H counts was equivalent in the two gradients (4, Centrifugation of rhinoviruses into CsCl gradients has resulted in loss of infectivity (9) and also resulted in an artificial increase in the sedimentation coefficient of RV14 virus particles (5). To rule out that CsCl was involved in fragmentation of RV14 RNA, [3H ]uridinelabeled virus was purified by centrifugation into sucrose gradients. Virus particles purified by this technique were held at -90 C or incubated for 48 h at 34.5 C. The loss in infectivity in the particles after incubation was 74%. Recovery of counts per minute in 31S RNA/total counts per minute in sucrose gradients was 43 and 23% for RNA extracted from unincubated and incubated virus particles, respectively.
The fragility of isolated viral RNA during incubation at 34.5 C was examined in the following experiment. RNA was extracted from CsCl-purified virus particles and held at -90 C or incubated at 34.5 C for 48 h prior to centrifugation into sucrose gradients. The results (Fig.  2) show that genomic RNA per se does not undergo the extensive fragmentation observed for RNA extracted after incubation of virus particles. The specific infectivities of RNA in the unincubated and incubated samples were 23.5 and 21.9 PFU per count per min, respectively.
Several properties of purified, incubated virus particles were measured to determine if incubation at 34.5 C resulted in physical alteration of the particles. All virus preparations in the following four experiments showed reductions in titers of 65 to 88% after incubation at 34.5 C. Buoyant densities of unincubated and incubated (48 h) particles in CsCl were 1.410 ± 0.002 and 1.411 i 0.002 g/ml for two different virus preparations. Incubated (48 h) [3Hluri-dine-labeled purified virus particles were found to cosediment with unincubated 3P-labeled virus particles after centrifugation into linear 5 to 30% sucrose gradients (identical results were obtained when the labeled precursors were re- . CsCl-or sucrose-gradient-purified RV14 particles were incubated at 34.5 C for 48 h or held at -90 C, and then one-half of each sample was incubated with pancreatic RNase (50 yg/ml) for 30 min at 37 C. Plaque assay of these samples showed that the RNase-treated preparations contained from 97 to 121% of the infectivity present in the corresponding untreated samples. These results show that particles incubated at 34.5 C do not undergo gross physical alterations in density, size, or capsid integrity. The possibility that RNA fragmentation was a result of RNase in the milieu which attacks sites on the genome during incubation at 34. 
